Management of canine CHF (Yr 3) Flashcards
what are the four main consequences of heart failures?
vasoconstriction
tachycardia
myocardial remodelling/fibrosis
oedema/effusions
what is the immediate life threatening issue associated with left sided CHF?
pulmonary oedema
what is the main immediate problem associated with CHF?
sodium and water retention
what effects does the sodium/water retention in right sided CHF?
ascites, hepatomegaly, pleural effusion
what is the first choice treatment for oedema and effusions?
diuretics (furosemide)
what is the first choice diuretic?
furosemide
how much furosemide should be given in chronic cases?
lowest dose possible to control the clinical signs
how do you titrate furosemide to effect?
owner monitors the sleeping/resting respiratory rate and then can reduce dose if there is no increase in respiratory rate (very sensitive way of monitoring how controlled CHF is)
what are the main two side effects of furosemide?
pre-renal azotaemia
hypokalaemia
(must monitor renal function)
what needs to be monitored when a patient is on diuretics such as furosemide?
renal function (urea, creatinine, electrolytes)
should furosemide be used on its own?
should be used as monotherpay long term as it activates RAAS (leading to more remodelling/fibrosis)
what should be done if furosemide is no longer working and you have reached the maximum dose?
ensure optimised use of ACE inhibitors
consider parenteral administration (GIT oedema in right sided CHF can inhibit absorption)
resistance can develop so consider other diuretics (sequential nephron blockade)
consider swapping for another loop diuretic (torasemide)
what diuretics can be added to furosemide for sequential nephron blockade?
spironolactone
amiloride/hydrochlorothiazide
(need to monitor renal function)
what type of drug is spironolactone?
aldosterone antagonist
potassium sparing diuretic
is thoracocentesis indicated with pleural effusions caused by CHF?
yes (don’t wait until diuretics take effect!!)
how do ACE inhibitors work?
counteract adverse effects of angiotensin II